The estimated Net Worth of Amir Elstein is at least $38 Million dollars as of 15 June 2024. Mr. Elstein owns over 21,108 units of Teva- Pharmaceutical Industries stock worth over $37,614,185 and over the last 6 years he sold TEVA stock worth over $0. In addition, he makes $340,508 as Independent Director at Teva- Pharmaceutical Industries.
Amir has made over 7 trades of the Teva- Pharmaceutical Industries stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 21,108 units of TEVA stock worth $379,100 on 15 June 2024.
The largest trade he's ever made was exercising 21,108 units of Teva- Pharmaceutical Industries stock on 15 June 2024 worth over $379,100. On average, Amir trades about 5,980 units every 92 days since 2018. As of 15 June 2024 he still owns at least 2,094,331 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Mr. Elstein stock trades at the bottom of the page.
Amir Elstein serves as Independent Director of the Company. Mr. Elstein serves as Chairman of the Board of Tower Semiconductor Ltd. and Chairman of the Israel Democracy Institute. Mr. Elstein also serves as Chairman or as a member of the board of directors of several academic, scientific, educational, social and cultural institutions. Mr. Elstein served as Chairman of the Board of Governors of the Jerusalem College of Engineering from 2009 to 2018 and as Chairman of the Board of Directors of Israel Corporation from 2010 to 2013. From 2004 to 2008, Mr. Elstein was a member of Teva’s senior management, most recently as Executive Vice President, Global Pharmaceutical Resources. From 1995 to 2004, Mr. Elstein served on Teva’s Board of Directors. Prior to joining Teva as an executive in 2004, Mr. Elstein held a number of executive positions at Intel Corporation, most recently as General Manager of Intel Electronics Ltd., an Israeli subsidiary of Intel Corporation.
As the Independent Director of Teva- Pharmaceutical Industries, the total compensation of Amir Elstein at Teva- Pharmaceutical Industries is $340,508. There are 13 executives at Teva- Pharmaceutical Industries getting paid more, with Kaare Schultz having the highest compensation of $11,596,600.
Amir Elstein is 64, he's been the Independent Director of Teva- Pharmaceutical Industries since 2014. There are 3 older and 25 younger executives at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director.
Amir's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020.
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over $31,332,399 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 . The most active insiders traders include Sol J Barer, Tal Zvi Zaks, and Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of $636,538. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth $231,181.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: